German team has developed new technique giving 'personalised treatment'Tests carried out on cancerous cells in lung, skin and bowel tumours . 
 Survival rates boosted by more than 50 per cent during animal trials . 
 Patients with skin cancer now being recruited for the first human trials . 
 